These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30116610)

  • 21. The Hyperintense study: Assessing the effects of induced blood pressure increase and decrease on MRI markers of cerebral small vessel disease: Study rationale and protocol.
    Janssen E; Ter Telgte A; Verburgt E; de Jong JJ; Marques JP; Kessels RP; Backes WH; Maas MC; Meijer FJ; Deinum J; Riksen NP; Tuladhar AM; de Leeuw FE
    Eur Stroke J; 2022 Sep; 7(3):331-338. PubMed ID: 36082259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebral microangiopathy of diabetes].
    Li Y; Zeng KW; Wang XM
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2247-2253. PubMed ID: 28822176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Antihypertensive Medication on Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.
    van Middelaar T; Argillander TE; Schreuder FHBM; Deinum J; Richard E; Klijn CJM
    Stroke; 2018 Jun; 49(6):1531-1533. PubMed ID: 29739911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
    Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
    [No Abstract]   [Full Text] [Related]  

  • 25. Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator?
    Parodi L; Mayerhofer E; Narasimhalu K; Yechoor N; Comeau ME; Rosand J; Langefeld CD; Anderson CD
    J Am Heart Assoc; 2023 Jul; 12(13):e029862. PubMed ID: 37345795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate.
    Mishra A; Duplaà C; Vojinovic D; Suzuki H; Sargurupremraj M; Zilhão NR; Li S; Bartz TM; Jian X; Zhao W; Hofer E; Wittfeld K; Harris SE; van der Auwera-Palitschka S; Luciano M; Bis JC; Adams HHH; Satizabal CL; Gottesman RF; Gampawar PG; Bülow R; Weiss S; Yu M; Bastin ME; Lopez OL; Vernooij MW; Beiser AS; Völker U; Kacprowski T; Soumare A; Smith JA; Knopman DS; Morris Z; Zhu Y; Rotter JI; Dufouil C; Valdés Hernández M; Muñoz Maniega S; Lathrop M; Boerwinkle E; Schmidt R; Ihara M; Mazoyer B; Yang Q; Joutel A; Tournier-Lasserve E; Launer LJ; Deary IJ; Mosley TH; Amouyel P; DeCarli CS; Psaty BM; Tzourio C; Kardia SLR; Grabe HJ; Teumer A; van Duijn CM; Schmidt H; Wardlaw JM; Ikram MA; Fornage M; Gudnason V; Seshadri S; Matthews PM; Longstreth WT; Couffinhal T; Debette S
    Brain; 2022 Jun; 145(6):1992-2007. PubMed ID: 35511193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of cerebral small vessel disease.
    Choi JC
    J Stroke; 2015 Jan; 17(1):7-16. PubMed ID: 25692103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Trajkovic JZ; Tomic G; Cvitan E; Sternic N
    J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1260-1265. PubMed ID: 30058256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between periodic limb movements during sleep and neuroimaging features of cerebral small vessel disease: A preliminary cross-sectional study.
    Ouyang F; Wang M; Liao M; Lan L; Liu X; Li H; Mo R; Shi L; Fan Y
    J Sleep Res; 2022 Oct; 31(5):e13573. PubMed ID: 35224805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the Causal Association between Biological Aging Biomarkers and the Development of Cerebral Small Vessel Disease: A Mendelian Randomization Study.
    Lin B; Mu Y; Ding Z
    Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.
    Akinyemi RO; Owolabi MO; Ihara M; Damasceno A; Ogunniyi A; Dotchin C; Paddick SM; Ogeng'o J; Walker R; Kalaria RN
    Brain Res Bull; 2019 Feb; 145():97-108. PubMed ID: 29807146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of the heterogeneous expression of flippase ATP11B leads to cerebral small vessel disease in a normotensive rat model.
    Quick S; Procter TV; Moss J; Seeker L; Walton M; Lawson A; Baker S; Beletski A; Garcia DJ; Mohammad M; Mungall W; Onishi A; Tobola Z; Stringer M; Jansen MA; Vallatos A; Giarratano Y; Bernabeu MO; Wardlaw JM; Williams A
    Acta Neuropathol; 2022 Aug; 144(2):283-303. PubMed ID: 35635573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Small Vessel Disease and Stage 1 Hypertension Defined by the 2017 American College of Cardiology/American Heart Association Guidelines.
    Nam KW; Kwon HM; Jeong HY; Park JH; Kwon H; Jeong SM
    Hypertension; 2019 Jun; 73(6):1210-1216. PubMed ID: 31067203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain.
    Craggs LJ; Yamamoto Y; Deramecourt V; Kalaria RN
    Brain Pathol; 2014 Sep; 24(5):495-509. PubMed ID: 25323665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical symptoms and risk factors in cerebral microangiopathy patients.
    Okroglic S; Widmann CN; Urbach H; Scheltens P; Heneka MT
    PLoS One; 2013; 8(2):e53455. PubMed ID: 23393549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of neuroimaging research progress of cerebral small vessel disease.
    Wang J; Wang B; Wang K
    Folia Neuropathol; 2023; 61(1):1-7. PubMed ID: 37114955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracranial Arterial Dolichoectasia and Stenosis: Risk Factors and Relation to Cerebral Small Vessel Disease.
    Zhai FF; Yan S; Li ML; Han F; Wang Q; Zhou LX; Ni J; Yao M; Zhang SY; Cui LY; Jin ZY; Zhu YC
    Stroke; 2018 May; 49(5):1135-1140. PubMed ID: 29581240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function: The Second Manifestations of Arterial Disease-Magnetic Resonance Study.
    van der Veen PH; Geerlings MI; Visseren FL; Nathoe HM; Mali WP; van der Graaf Y; Muller M;
    Hypertension; 2015 Dec; 66(6):1152-8. PubMed ID: 26503971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals.
    Affleck AJ; Sachdev PS; Halliday GM
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12922. PubMed ID: 37431095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia.
    Gyanwali B; Tan CS; Petr J; Escobosa LLT; Vrooman H; Chen C; Mutsaerts HJ; Hilal S
    AJNR Am J Neuroradiol; 2022 Oct; 43(10):1418-1423. PubMed ID: 36562454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.